Week of April 12th, 2021 | Vol. 10, Issue 15
In This Issue
Featured Headlines
Recent Industry Transactions
Industry Trading Comps
Recent Industry Headlines
Market Reports
Upcoming Events

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory

Above is an overview of recent industry M&A activity. For additional information, see the charts below or click on the chart above to download complete transaction tables broken out by industry sub sectors.

For more information about our consumer healthcare JV with The Emerson Group, Daybreak Consumer Care, click here.
Recent Materials Providing Insight Into Healthcare Related Industries
Current M&A Pipeline
Representative Current Retained Sell-Side And Partnering Opportunities
Project Tribute
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in Canada

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics

Project Aspen
Sell-side | CDMO | Multinational CDMO headquartered in US

Project Athena
Sell-side / Licensing | Medical Device | Novel device for pelvic organ prolapse

ANI Pharmaceuticals Inc. has acquired the new drug applications (NDAs) for Oxistat Lotion, Veregen Ointment, and Pandel Cream and the abbreviated new drug application (ANDA) for ApexiCon E Cream from Sandoz Inc. Pandel Cream will be transitioned later upon receiving the requisite approvals.
Collectively, these products generated net revenues of $13.2 million in 2020. The acquisition was funded through borrowings under the Company’s pre-existing revolver credit facility.

An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
Pharma & Biotech
14 transactions totaling $1,135 million
Supplies, Equipment & Services
25 transactions totaling $67 million
Healthcare IT & Managed Care
6 transactions totaling $108 million
Healthcare Facilities & Distributors
11 transactions totaling $239 million
Pharma & Biotech
30 transactions totaling $841 million
Supplies, Equipment & Services
26 transactions totaling $277 million
Healthcare IT & Managed Care
17 transactions totaling $436 million
Healthcare Facilities & Distributors
1 transaction
Pharma & Biotech
19 transactions totaling $1,956 million
Supplies, Equipment & Services
9 transactions totaling $2,206 million
Healthcare IT & Managed Care
4 transaction totaling $389 million
Healthcare Facilities & Distributors
1 transaction
A Breakdown of Relevant Trading Multiples
Each week, we provide updated trading comps for leading companies from numerous healthcare sub-sectors.
To the right you will see a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
A Sampling of Relevant Industry Headlines from Last Week
Below are snippets from relevant industry news articles from the past week. For additional information or the article's complete text, click the headline link to view the original publication.
April 12, 2021 - Fierce Biotech
Sanofi has paid $160 million upfront to buy a preclinical biotech that is using mRNA to reprogram immune cells inside the human body. The technology could enable patients to make their own CAR-T cells, eliminating the complex cell therapy supply chain while improving safety and dosing.

April 9, 2021 - Contract Pharma
Ascendia Pharmaceuticals, a specialty contract development and manufacturing organization (CDMO) dedicated to developing and manufacturing enhanced formulations for pre-clinical, clinical stage drug candidates, and marketed drug products, has received an investment made by Signet Healthcare Partners, a New York-based growth equity firm specializing in healthcare investments. The proceeds will be used to fund Ascendia’s facility expansion to support the growing demand in the sector.

April 9, 2021 - Contract Pharma
Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals, has added roller compaction technology to its solid dose capability offerings at its Zhunan, Taiwan contract manufacturing and packaging facility. The Zhunan facility manufacturers complex oral solid dose (OSD) formulations with expertise in the use of solvents, Wurster Coating, or Extrusion-Spheronization.

April 8, 2021 - Fierce Healthcare
The combination of the two companies reflects a shared vision: lowering costs and providing greater access to quality, affordable, personalized care, according to a press release issued by Cain Brothers, Zipnosis’ financial adviser.
Welcome to Bourne, let's talk.

Since our founding in 2001, Bourne Partners has remained focused on fulfilling the unique needs of established, middle-market healthcare and pharmaceutical companies across the globe. Our track record includes advising middle market companies in healthcare M&A assignments totaling more than $7 billion, and growing companies into successful and well-positioned pharmaceutical enterprises.